A gene encoding carrageenase and its encoded product and application

By expressing and purifying carrageenase Cgk-GDSX477, the problem of poor stability of existing carrageenase at high temperature is solved, and the efficient enzymatic decomposition effect is achieved under a wide range of temperature and pH conditions is provided, providing a heat resistance and Stable carrageenase is used to prepare carrageenan oligosaccharides.

CN118773223BActive Publication Date: 2024-12-03GUANGDONG OCEAN UNIVERSITY +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411273108.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-12
Publication Date
2024-12-03
Estimated Expiration
2044-09-12

AI Technical Summary

Technical Problem

The existing carrageenase has poor stability at conditions above 40°C, and the enzyme activity loss is large, making it difficult to maintain efficient activity under a wide range of temperature and pH conditions.

Method used

A gene encoding carrageenase Cgk-GDSX477 and its recombinant expression vector are provided. By expressing and purifying carrageenase in E. coli BL21 (DE3), the enzyme is stable within the range of 4~70℃ and pH 3.0~11.0. Sex and activity.

Benefits of technology

Carrageenase Cgk-GDSX477 maintains high relative activity at 4~70°C and has the best activity at pH 8.0 or 9.0. It can effectively degrade κ-carrageenan to produce κ-neocarra tetrasaccharide and κ-neocarra Hexa sugar significantly improves the heat resistance and stability of the enzyme.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118773223B_ABST
    Figure CN118773223B_ABST
Patent Text Reader

Abstract

The present invention discloses a gene encoding carrageenase and its encoding product and application, belonging to the technical field of biological enzymes. Cgk‑GDSX477 The nucleotide sequence is shown in SEQ ID NO:1, and the amino acid sequence of the carrageenase Cgk-GDSX477 encoded by the gene is shown in SEQ ID NO:2. The carrageenase Cgk-GDSX477 has good relative activity at 4-70°C and is relatively stable in a buffer system of pH 3.0-11.0. The carrageenase provided by the present invention can degrade κ-carrageenan to obtain carrageenan oligosaccharides, which include κ-neocalanetetrose and κ-neocalahexaose. The present invention provides a carrageenase with good heat resistance and stability for enzymatic hydrolysis of carrageenan.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biological enzymes and relates to a gene encoding carrageenase and its encoding product and application. Background Art

[0002] Carrageenan ( Carrageenan ) is a hydrophilic colloid, also known as euchelin gum, agar, carrageenan, and carrageenan. It is a hydrophilic colloid extracted from red algae seaweeds such as euchelin gum, agar, and carrageenan. It has a repeating α-1,4-D-galactopyranose-β-1,3-D-galactopyranose disaccharide unit skeleton structure. The main component of carrageenan is cellulose, which will swell and form a stable colloid when it comes into contact with water. It can stabilize the texture of food and improve the taste. It is often used as a thickener, gelling agent, suspending agent, emulsifier and stabilizer. Carrageenan is also widely used in the medical field. Studies have found that carrageenan has antiviral, immunomodulatory, anticoagulant, antioxidant, and anti-cancer biological activities.

[0003] Carrageenan oligosaccharides are degradation products of carrageenan. Compared with carrageenan, they have lower molecular weight, higher solubility, easier absorption, better stability and safety. At the same time, because the active groups on the molecular chain are fully exposed, their activity is significantly improved compared with carrageenan, and even new activities are generated. Carrageenan oligosaccharides have immunomodulatory, anti-tumor, anti-radiation, antibacterial, antiviral, antioxidant, anticoagulant and other activities. At present, there are many methods for preparing carrageenan oligosaccharides by microbial enzyme degradation of carrageenan. Compared with the traditional acid hydrolysis method, the enzyme degradation method has the advantages of specific recognition site and cleavage site, uniform product, mild mode of action, no destructive effect on raw materials and products, and simple purification. However, the stability of the carrageenase reported so far is poor, and the enzyme activity loss is large under conditions above 40°C. Therefore, it is of great significance to provide a carrageenase with good heat resistance and stability. Summary of the invention

[0004] In order to study a carrageenase with good heat resistance and stability, the present invention provides a gene encoding carrageenase and its encoded product and application. The gene is Cgk-GDSX477 , whose nucleotide sequence is shown in SEQ ID NO:1, and the amino acid sequence of the gene encoding product carrageenase Cgk-GDSX477 is shown in SEQ ID NO:2. Carrageenase Cgk-GDSX477 has good relative activity at 4-70°C, is relatively stable in a buffer system of pH 3.0-11.0, and can degrade κ-carrageenan to obtain κ-neocalanetetrose and κ-neocalahexaose. The present invention provides a carrageenase with good heat resistance and stability for enzymatic hydrolysis of carrageenan.

[0005] To achieve the technical purpose of the present invention, on the one hand, the present invention provides a gene encoding carrageenase, the gene is Cgk-GDSX477 , whose nucleotide sequence is shown in SEQ ID NO:1.

[0006] On the other hand, the present invention seeks to protect a recombinant expression vector comprising the above-mentioned gene encoding carrageenase, and the gene encoding carrageenase is connected to the expression vector pET-28a(+) to obtain a recombinant expression vector.

[0007] Furthermore, the present invention Cgk-GDSX477 and the E. coli expression vector pET-28a(+) were double-digested with restriction endonucleases NdeI and xhoI, respectively, and the recovered fragments were connected to the E. coli expression vector digested at the same site to obtain a recombinant expression vector.

[0008] On the other hand, the present invention claims protection for a recombinant engineered bacterium, comprising the above-mentioned gene encoding carrageenase or recombinant expression vector, wherein the host of the recombinant engineered bacterium is BL21 (DE3).

[0009] Furthermore, the present invention transforms BL21 (DE3) competent cells with a recombinant expression vector, spreads on an LB agar plate with kanamycin resistance, cultures overnight at 37°C, picks a single clone for positive verification and identification sequencing. The correctly sequenced single clone is re-inoculated on an LB agar plate with kanamycin resistance to obtain a recombinant engineered bacterium.

[0010] In another aspect, the present invention claims a carrageenase encoded by the above carrageenase-producing gene or produced by a recombinant engineered bacterium. The carrageenase is Cgk-GDSX477, and its amino acid sequence is shown in SEQ ID NO:2.

[0011] Furthermore, in the present invention, after activation, the recombinant engineered bacteria were inoculated with 100 mL of LB sterile liquid culture medium containing 50 μg / mL kanamycin at a volume ratio of 1% and cultured at 37°C and 220 rpm. When the bacterial solution OD 600 When the concentration of 1% β-glutamic acid was 0.5, 0.1 mM IPTG was added and induced at 30°C for 12 hours. After the fermentation, the culture solution was collected and centrifuged at 8000 rpm / min for 10 minutes, the bacteria were collected, resuspended with pH 8.0 phosphate buffer, ultrasonically broken in an ice bath for 30 minutes, the broken enzyme solution was centrifuged at 8000 rpm / min for 10 minutes, the supernatant was filtered through a 0.45 μm filter membrane, and the crude enzyme solution was collected for protein purification by Ni-NTA affinity chromatography. The amino acid sequence of the purified protein is shown in SEQ ID NO: 2, and the relative molecular weight is about 52 kDa as detected by SDS-PAGE.

[0012] In addition, the present invention claims the use of the above-mentioned carrageenase in enzymatic hydrolysis of carrageenan, the carrageenan is κ-carrageenan, the degradation product of κ-carrageenan is κ-carrageenan oligosaccharide, and κ-carrageenan oligosaccharide includes κ-neocalastatose and κ-neocalahexaose. The enzymatic hydrolysis temperature of carrageenase is 4-70°C, and a buffer solution of pH 3.0-11.0 is used to dissolve carrageenan; preferably, the enzymatic hydrolysis temperature of carrageenase is 40°C, and a buffer solution of pH 8.0 or pH 9.0 is used to dissolve carrageenan, the buffer solution of pH 8.0 is a phosphate buffer solution, and the buffer solution of pH 9.0 is a sodium carbonate buffer solution.

[0013] Further, the present invention detects the activity of carrageenase under 4-70°C and finds that carrageenase Cgk-GDSX477 has good relative activity at 4-70°C, and its optimum reaction temperature is 40°C. After dissolving carrageenan using a buffer solution of pH 3.0-11.0, the present invention adds carrageenase to detect the activity of the enzyme and finds that carrageenase Cgk-GDSX477 has good relative activity at pH 8.0 or pH 9.0, the buffer solution at pH 8.0 is a phosphate buffer solution, and the buffer solution at pH 9.0 is a sodium carbonate buffer solution, and its optimum reaction pH is 8.0 or 9.0. After mixing carrageenase with a buffer solution of pH 3.0-11.0, the present invention finds that carrageenase Cgk-GDSX477 is relatively stable in a buffer solution system of pH 3.0-11.0 and can play an enzymolysis role.

[0014] Furthermore, the present invention uses the above-mentioned carrageenanase to hydrolyze carrageenan to prepare carrageenan oligosaccharides. Through thin layer chromatography and liquid phase mass spectrometry analysis, it is found that the hydrolysis products after carrageenanase Cgk-GDSX477 hydrolyzes κ-carrageenan include κ-neocalanetetrose and κ-neocalahexaose.

[0015] Compared with the prior art, the technical solution provided by the present invention has at least the following beneficial effects or advantages:

[0016] The present invention provides a carrageenase with good heat resistance and stability for preparing carrageenan oligosaccharides by enzymatic degradation of carrageenan. The carrageenase Cgk-GDSX477 provided by the present invention has good relative activity at 4-70°C, and its optimum reaction temperature is 40°C; the carrageenase Cgk-GDSX477 provided by the present invention has good relative activity at pH 8.0 or pH 9.0, the buffer at pH 8.0 is a phosphate buffer, and the buffer at pH 9.0 is a sodium carbonate buffer, and its optimum reaction pH is 8.0 or 9.0. After the present invention mixes the carrageenase with a buffer at pH 3.0-11.0, it is found that the carrageenase Cgk-GDSX477 is relatively stable in a buffer system at pH 3.0-11.0, and can play an enzymatic role.

[0017] The present invention finds through thin layer chromatography and liquid phase mass spectrometry analysis that the enzymatic hydrolysis products of κ-carrageenan after carrageenase Cgk-GDSX477 hydrolyzes κ-carrageenan include κ-neocalanetetrose and κ-neocalahexaose, the characteristic ion peak of κ-neocalanetetrose is a peak with a mass-to-charge ratio m / z of 394.05, and the characteristic ion peak of κ-neocalahexaose is a peak with a mass-to-charge ratio m / z of 391.05. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings in the following description are only some embodiments of the present invention.

[0019] Figure 1 Gene encoding carrageenase Cgk-GDSX477 Agarose gel electrophoresis diagram.

[0020] Figure 2 This is the SDS-PAGE image of carrageenase Cgk-GDSX477.

[0021] Figure 3 The effect of different temperatures on the relative activity of carrageenase Cgk-GDSX477.

[0022] Figure 4 The effect of different pH on the relative activity of carrageenase Cgk-GDSX477.

[0023] Figure 5 The effect of different pH on the stability of carrageenase Cgk-GDSX477.

[0024] Figure 6 The results of TLC analysis of the hydrolysis products of carrageenase Cgk-GDSX477 at different hydrolysis times. Gal is galactose; two is the standard κ-neocalabiose; four is the standard κ-neocalabiose; six is ​​the standard κ-neocalahexaose; 1 to 15 are the hydrolysis times of 10 min, 0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, 12 h, 24 h, 30 h, 36 h, 48 h, and 72 h, respectively.

[0025] Figure 7 The total ion chromatograms of the enzymatic hydrolysis products of carrageenase Cgk-GDSX477 detected by mass spectrometry at different enzymatic hydrolysis times. DP4 is κ-neocalanetetrose; DP6 is κ-neocalahexaose.

[0026] Figure 8 This is the mass spectrometry detection result of κ-neocalabotetrose.

[0027] Fig. 9 This is the mass spectrometry detection result of κ-neocalahexose. DETAILED DESCRIPTION

[0028] The technical scheme of the present invention is described below in conjunction with the embodiments, but the present invention is not limited to the following embodiments. The experimental methods and detection methods described in each embodiment are conventional methods unless otherwise specified; the reagents and materials described are all commercially available unless otherwise specified.

[0029] LB agar plates and LB liquid medium were purchased from Sangon Biotech (Shanghai) Co., Ltd.

[0030] κ-Carrageenan was purchased from Qingdao Haida Marine Oligosaccharide Technology Co., Ltd.

[0031] Example 1

[0032] This example provides the preparation of carrageenase Cgk-GDSX477.

[0033] 1. Preparation of recombinant bacteria

[0034] The Lucidobacterium luminescens disclosed in the patent application number CN202311542969.7 ( Photobacterium rosenbergii ) The genome of GDSX-4 (deposit number GDMCC 63878) was used as a template to PCR amplify its enzyme gene (as shown in SEQ ID NO: 1). The upstream primer was designed with NdeI as the site 5′-GGAATTCCATATGAAATTACGTTATTTCTTGCT-3′, and the downstream primer was designed with xhoI as the site 5′-CCGCTCGAGTGGCTCGATGCTAGTTATCTTTA-3′. The PCR amplification system was 50μL (2×pfu PCR mix 25μL, upstream primer, downstream primer 2μL each, template 2μL, ddH2O 19μL), PCR amplification conditions were 94℃ 5min, 30 cycles (94℃ 30sec, 55℃ 30sec, 72℃ 40sec), 10℃ hold on, and the PCR product was detected by agarose gel electrophoresis. The results are as follows Figure 1 As shown. Figure 1 It can be seen that the enzyme-producing gene was amplified by PCR Cgk- GDSX477 , with a size of 1353bp.

[0035] The PCR product and the E. coli expression vector pET-28a(+) (purchased from Hangzhou Baosai Biotechnology Co., Ltd.) were double-digested with restriction endonucleases (NdeI-xhoI), and the recovered fragments were connected to the E. coli expression vector digested at the same site and transformed into BL21 (DE3) competent cells (purchased from Hangzhou Baosai Biotechnology Co., Ltd.), spread on LB agar plates (containing 30μg / mL kanamycin), and cultured at 37℃ overnight. Single clones were picked for positive verification and identification and sequencing. The single clones with correct sequencing were re-inoculated on LB agar plates (containing 30μg / mL kanamycin) to obtain recombinant bacteria.

[0036] 2. Preparation of carrageenase Cgk-GDSX477

[0037] The recombinant bacteria were activated in 5 mL of LB sterile liquid medium (containing 50 μg / mL kanamycin), and inoculated into 100 mL of LB sterile liquid medium (containing 50 μg / mL kanamycin) at a volume ratio of 1% for expansion culture at 37°C and 220 rpm. 600 When the pH was 0.5, 0.1 mM IPTG was added and induced at 30°C for 12 h.

[0038] After the fermentation, the culture solution was collected and centrifuged at 8000rpm / min for 10min, the bacteria were collected, resuspended in phosphate buffer at pH 8.0, and ultrasonically disrupted in an ice bath for 30min. The enzyme solution was centrifuged at 8000rpm / min for 10min, the supernatant was filtered through a 0.45μm filter membrane, and the crude enzyme solution was collected for protein purification by Ni-NTA affinity chromatography. The amino acid sequence of the purified protein (carrageenase Cgk-GDSX477) is shown in SEQ ID NO: 2. The results of SDS-PAGE detection are as follows: Figure 2 As shown, a single band of electrophoretic pure protein was obtained, with a relative molecular weight of approximately 52 kDa.

[0039] Example 2

[0040] This example provides the determination of the reaction conditions for carrageenase Cgk-GDSX477.

[0041] Carrageenase activity assay: 490 μL substrate (0.2% κ-carrageenan) and 10 μL carrageenase Cgk-GDSX477 were reacted at 40°C for 30 min, 500 μL DNS reagent was added and mixed, and the mixture was boiled for 10 min for color development.

[0042] 1. Determination of reaction temperature of carrageenase Cgk-GDSX477

[0043] The reaction temperatures in the enzyme activity assay were 4, 20, 30, 40, 50, 60, and 70 °C, respectively. Each test was performed in triplicate to calculate the relative activity of carrageenase Cgk-GDSX477 ( Figure 3 ).

[0044] The calculation formula of relative activity is: relative activity = enzyme activity value / highest enzyme activity value in the same group × 100%.

[0045] Depend on Figure 3 It can be seen that carrageenase Cgk-GDSX477 has good relative activity at 4~70℃, and its optimal reaction temperature is 40℃.

[0046] 2. Determination of pH of carrageenase Cgk-GDSX477 reaction

[0047] 1) In the enzyme activity assay, a buffer of pH 3.0-11.0 (pH 3.0-6.0 is citric acid buffer, pH 6.0-8.0 is phosphate buffer, pH 8.0-10.0 is Tris-HCl buffer, and pH 9.0-11.0 is sodium carbonate buffer) was used to dissolve the substrate. Each test was performed in triplicate to calculate the relative activity of carrageenase Cgk-GDSX477 ( Figure 4 ).

[0048] Depend on Figure 4 It can be seen that carrageenase Cgk-GDSX477 has better relative activity at pH 8.0 or pH 9.0. At pH 8.0, the buffer is phosphate buffer, and at pH 9.0, the buffer is sodium carbonate buffer. The optimal reaction pH is 8.0 or 9.0.

[0049] 2) Carrageenase Cgk-GDSX477 was mixed with the above-mentioned buffer solutions of pH 3.0-11.0, and allowed to stand for 24 hours. The relative activity of carrageenase Cgk-GDSX477 in different pH buffer systems was determined. Each test was performed in triplicate. The results were as follows: Figure 5 shown.

[0050] Depend on Figure 5 It can be seen that carrageenase Cgk-GDSX477 is relatively stable in the buffer system of pH 3.0~11.0 and can play an enzymatic role.

[0051] Example 3

[0052] This example provides the use of carrageenase Cgk-GDSX477 in degrading carrageenan.

[0053] Preparation of enzymatic oligosaccharides: 0.5% κ-carrageenan substrate solution was prepared with phosphate buffer (pH 8.0), 10% enzyme solution was added according to the total reaction volume, and the reaction was carried out at 40°C for 10 min, 0.5 h, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h, 8 h, 12 h, 24 h, 30 h, 36 h, 48 h, and 72 h, respectively. The reaction was terminated by heating and boiling for 10 min and then cooled to room temperature.

[0054] Analysis of κ-carrageenan oligosaccharides by thin layer chromatography: Activate a silica gel thin layer plate in a drying oven at 100°C for 1h, spot 3μL of the above sample on the silica gel plate, use galactose (Gal), standard κ-neocalabiose (diose), standard κ-neocalabiose (tetraose), standard κ-neocalabiose (hexaose) as controls, develop in a developing agent of n-butanol:ethanol:water (3:2:2), blow dry, soak in a color developer (2g diphenylamine, 2mL aniline, 10mL 85% phosphoric acid, 1mL concentrated hydrochloric acid, 100mL acetone), blow dry, heat at 110°C for 10min for color development, and the results of thin layer chromatography are as follows: Figure 6 As shown. Figure 6 It can be seen that the enzymatic hydrolysis products of κ-carrageenan after carrageenanase Cgk-GDSX477 hydrolyzes κ-carrageenan are mainly composed of κ-neocalanetetrose and κ-neocalahexaose.

[0055] Liquid phase mass spectrometry (Q-TOF-MS) analysis of degradation product structure: The reaction solution of the above process was diluted to 50μg / mL, filtered through a 0.22μm microporous filter membrane, and injected into the TOF-MS system for analysis. The chromatographic conditions were: injection volume 5μL; mobile phase: acetonitrile: 1mM formic acid (1:1); flow rate 0.2mL / min; column temperature 35℃. The mass spectrometer used an ESI point spray ion source, negative ion ionization mode; mass scanning range: m / z 50~2000Da. The ESI-MS detection results are as follows Figure 7 As shown, the mass spectrum of κ-neocalatetraose (DP4) is as follows Figure 8 As shown, the mass spectrum of κ-neocalahexose (DP6) is as follows Fig. 9 as shown.

[0056] Depend on Figure 7~Figure 9 It can be seen that the enzymatic hydrolysis products of κ-carrageenan by carrageenase Cgk-GDSX477 are κ-neocalanetetrose and κ-neocalahexaose. The characteristic ion peak of κ-neocalanetetrose is the peak with a mass-to-charge ratio of m / z 394.05, and the characteristic ion peak of κ-neocalahexaose is the peak with a mass-to-charge ratio of m / z 391.05.

[0057] The embodiments described above are part of the embodiments of the present invention, but not all of them. The detailed description of the embodiments of the present invention is not intended to limit the scope of the invention claimed for protection, but only represents selected embodiments of the present invention. All other embodiments obtained without creative work and related deductions and substitutions made by ordinary technicians in the field under the conditions of the concept of the present invention belong to the scope of protection of the present invention.

Claims

1. A gene encoding carrageenase, characterized in that: The gene is Cgk-GDSX477 The nucleotide sequence of the gene is shown in SEQ ID NO:

1.

2. A recombinant expression vector, characterized in that: The gene encoding carrageenase according to claim 1 is connected to the expression vector pET-28a(+) to obtain the recombinant expression vector.

3. A recombinant engineered bacterium, characterized in that: It comprises the gene encoding carrageenase according to claim 1 or the recombinant expression vector according to claim 2.

4. The recombinant engineered bacterium according to claim 3, characterized in that The host of the recombinant engineering bacteria is Escherichia coli; The Escherichia coli is BL21 (DE3).

5. A carrageenase, characterized in that Produced by the gene encoding carrageenase according to claim 1, or produced by the recombinant engineered bacteria according to claim 3; The carrageenase is Cgk-GDSX477, and its amino acid sequence is shown in SEQ ID NO:

2.

6. The use of the carrageenase according to claim 5 in enzymatic hydrolysis of carrageenan, characterized in that: The carrageenan is κ-carrageenan, and the enzymatic hydrolysis product of the κ-carrageenan is κ-carrageenan oligosaccharide, and the κ-carrageenan oligosaccharide includes κ-neocalastatose and κ-neocalahexaose; The enzymatic hydrolysis temperature of the carrageenase is 4-70°C; Dissolving the carrageenan using a pH 8.0 buffer or a pH 9.0 buffer; The pH 8.0 buffer is a phosphate buffer, and the pH 9.0 buffer is a sodium carbonate buffer.

7. The use according to claim 6, characterized in that: The enzymatic hydrolysis temperature of the carrageenase is 40°C.